首页> 中文期刊> 《临床医药实践》 >子宫动脉栓塞术后复发性子宫肌瘤的疗效分析

子宫动脉栓塞术后复发性子宫肌瘤的疗效分析

         

摘要

目的:评价子宫动脉栓塞治疗术后复发性子宫肌瘤的可行性和有效性,探索复发性子宫肌瘤的治疗方法。方法:采用回顾性研究方法分析40例子宫肌瘤剜除术后复发性子宫肌瘤接受了双侧子宫动脉栓塞治疗后的临床效果及术后随访结果。结果:所有病例术后随访12个月。术后3个月、6个月及12个月的临床症状改善率分别为80%,84%和90%。肌瘤平均缩小率为22.7%,46.2%和70.5%。术后12个月子宫体积平均缩小率为63.7%。40例术后均无严重并发症。结论:对于子宫肌瘤剜除术后复发性子宫肌瘤患者,子宫动脉栓塞术是一种安全有效的微创治疗手段。%Toevaluatethesafetyandcurativeeffectoftranscatheteruterinearterialembolizationintreatment of recurrent hysteromyoma,to poke the treatemnt of recurrent hysteromyoma. Methods:Performing retrospective study on 40 pa-tients suffering from recurrent hysteromyoma after myomectomy and treated by using transcatheter uterine arterial embolization. These patients were followed up for 3 to 12 mouths postoperatively. Results:The symptom improved rates after operation 3 months,6 months and 12 months were 80%,84% and 90%,respectively. The sizes of hysteromyomas were lessened,with rates of 22. 7%,46. 2% and 70. 5% respectively after these periods,so were the uteruses with the rate of 63. 7%. The clinical symptoms were improved and without severe complications postoperatively. Conclusion:It is an safe and effective method to treat recurrent hysteromyoma by using transcatheter uterine arterial embolization.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号